ENTRY       D11467                      Drug
NAME        Cinpanemab (USAN)
FORMULA     C6294H9744N1676O1990S46
EXACT_MASS  142117.9945
MOL_WEIGHT  142205.7384
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVEPGGSLRL SCAVSGFDFE KAWMSWVRQA PGQGLQWVAR IKSTADGGTT
            SYAAPVEGRF IISRDDSRNM LYLQMNSLKT EDTAVYYCTS AHWGQGTLVT VSSASTKGPS
            VFPLAPSSKS TSGGTAALGC LVKDYFPEPV TVSWNSGALT SGVHTFPAVL QSSGLYSLSS
            VVTVPSSSLG TQTYICNVNH KPSNTKVDKR VEPKSCDKTH TCPPCPAPEL LGGPSVFLFP
            PKPKDTLMIS RTPEVTCVVV DVSHEDPEVK FNWYVDGVEV HNAKTKPREE QYNSTYRVVS
            VLTVLHQDWL NGKEYKCKVS NKALPAPIEK TISKAKGQPR EPQVYTLPPS REEMTKNQVS
            LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK SRWQQGNVFS
            CSVMHEALHN HYTQKSLSLS PG
            (Light chain)
            SYELTQPPSV SVSPGQTARI TCSGEALPMQ FAHWYQQRPG KAPVIVVYKD SERPSGVPER
            FSGSSSGTTA TLTITGVQAE DEADYYCQSP DSTNTYEVFG GGTKLTVLSQ PKAAPSVTLF
            PPSSEELQAN KATLVCLISD FYPGAVTVAW KADSSPVKAG VETTTPSKQS NNKYAASSYL
            SLTPEQWKSH RSYSCQVTHE GSTVEKTVAP TECS
            (Disulfide bridge: H22-H98, H140-H196, H216-L213, H222-H'222, H225-H'225, H257-H37, H363-H421, H'22-H'98, H'140-H'196, H'216-L'213, H'257-H'317, H'363-H'421, L22-L87, L136-L195, L'22-L'87, L'136-L'195)
  TYPE      Peptide
EFFICACY    Antiparkinsonian, Anti-synuclein alpha antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of Parkinson's disease
TARGET      SNCA [HSA:6622] [KO:K04528]
  PATHWAY   hsa05012(6622)  Parkinson disease
BRITE       Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Cellular process
               Membrane trafficking
                SNCA
                 D11467  Cinpanemab (USAN)
DBLINKS     CAS: 2094516-02-4
            PubChem: 384585443
///
